100% Secure Payments
Tender Details
- Country: United Kingdom
- Summary: NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
- GBT Ref No: 116660374
- Deadline: 11 Apr 2025
- Competition: ICB
- Financier: Self Financed
- Purchaser Ownership: Public
- Tender Value: 1819623796
- Notice Type: Tender
- Document Ref. No.:
- Purchaser's Detail :
- Description :
- Provision of Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; • neovascular (wet) age-related macular degeneration (AMD) • visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) • proliferative diabetic retinopathy (PDR) • visual impairment due to diabetic macular oedema (DME) • visual impairment due to diabetic macular oedema (DME) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy • vision impairment associated with chronic diabetic macular oedema, (DME) • visual impairment due to myopic choroidal neovascularisation (myopic CNV) • retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 2+ or 3+) or AP-ROP (aggressive posterior ROP) disease • inflammation of the posterior segment of the eye presenting as non-infectious uveitis • prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye
Notice identifier : 2025/S 000-010548
CPV classifications: 33600000 - Pharmaceutical products33690000 - Various medicinal products - Documents :
Purchaser : NHS ENGLAND
Wellington House, 133-135 Waterloo Rd London SE1 8UG United Kingdom
Email :b.kullootee@nhs.net
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN
